Yahoo
LSE - Delayed Quote GBp

Reckitt Benckiser Group plc (RKT.L)

5,408.00 +126.00 (+2.39%)
At close: October 30 at 4:36:04 PM GMT
Chart Range Bar
Loading chart for RKT.L
  • Previous Close 5,282.00
  • Open 5,364.00
  • Bid 5,406.00 x --
  • Ask 5,408.00 x --
  • Day's Range 5,338.00 - 5,450.00
  • 52 Week Range 3,664.00 - 6,522.92
  • Volume 1,278,235
  • Avg. Volume 1,527,389
  • Market Cap (intraday) 34.252B
  • Beta (5Y Monthly) 0.28
  • PE Ratio (TTM) 12.18
  • EPS (TTM) 4.44
  • Earnings Date --
  • Forward Dividend & Yield 2.16 (4.00%)
  • Ex-Dividend Date Aug 6, 2026
  • 1y Target Est 6,268.53

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.

www.reckitt.com

36,200

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

RKT.L
13.43%
FTSE 100 (^FTSE)
8.04%

1-Year Return

RKT.L
10.85%
FTSE 100 (^FTSE)
9.94%

3-Year Return

RKT.L
6.13%
FTSE 100 (^FTSE)
46.43%

5-Year Return

RKT.L
12.18%
FTSE 100 (^FTSE)
48.25%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 3.17B
Earnings --
Profit Margin 0.00%

Q2

FY25

Q3

FY25

Q1

FY26

Q2

FY26

0
1B
2B
3B
0.0%

Analyst Insights

View More

Analyst Price Targets

5,352.00
6,268.53 Average
5,408.00 Current
7,660.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.09%

  • Return on Assets (ttm)

    7.88%

  • Return on Equity (ttm)

    48.02%

  • Revenue (ttm)

    13.64B

  • Net Income Avi to Common (ttm)

    2.89B

  • Diluted EPS (ttm)

    4.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    878M

  • Total Debt/Equity (mrq)

    179.74%

  • Levered Free Cash Flow (ttm)

    3.09B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: